Live Breaking News & Updates on Central Drugs Standards Control Organisation

Stay updated with breaking news from Central drugs standards control organisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amid concerns over new UK COVID-19 strain, vaccine maker submits data for emergency use

Amid concerns over new UK COVID-19 strain, vaccine maker submits data for emergency use
Apart from SII and Bharat Biotech, Pfizer has applied for the EUA so far but the US based pharma major has sought more time to make a detailed presentation before the Covid subject expert committee.
Share Via Email
| A+A A-
By Express News Service
NEW DELHI: One of the two Indian vaccine makers Serum Institute of India and Bharat Biotech has presented additional data demanded by the apex drug regulator in response to their application for emergency use authorization of Covid vaccine.
Apart from SII and Bharat Biotech, Pfizer has applied for the EUA so far but the US based pharma major has sought more time to make a detailed presentation before the Covid subject expert committee of the Central Drugs Standards Control Organisation. ....

United Kingdom , Rajesh Bhushan , National Task , News Service , Central Drugs Standards Control Organisation , Serum Institute Of India , Express News , Serum Institute , Bharat Biotech , Central Drugs Standards Control , Niti Aayog , ஒன்றுபட்டது கிஂக்டம் , ராஜேஷ் பூஷன் , தேசிய பணி , செய்தி சேவை , மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் , சீரம் நிறுவனம் ஆஃப் இந்தியா , எக்ஸ்பிரஸ் செய்தி , சீரம் நிறுவனம் , பாரத் பயோடெக் , மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு , நீதி ஆயோக் ,

India may need 1.3 lakh-1.4 lakh Covid vaccination centres: Study

India may need 1.3 lakh-1.4 lakh Covid vaccination centres: Study
Premium
(AP)
Share Via
Read Full Story
New Delhi: For Covid-19 vaccination, India may need 1.3 lakh-1.4 lakh vaccination centres, 1 lakh healthcare professionals as inoculators and 2 lakh support staff or volunteers to support government’s mass-inoculation program, a FICCI-EY knowledge paper has indicated.
The paper on private healthcare players to augment government’s capacity across the value chain of vaccine distribution and administration also highlighted that 81% of survey respondents from private healthcare industry are willing to inoculate frontline workers in local areas and 75% are willing to inoculate their local communities,70% are willing to allocate manpower in semi-urban/rural areas for vaccination and 94% are willing to impart training for inoculation. ....

Zydus Cadila , Krishna Ella , Convention On , Bharat Biotech International , Serum Institute , Indian Council Of Medical Research , Central Drugs Standards Control Organisation On , Serum Institute Of India , Bharat Biotech International Ltd , Annual Convention , Biotech Indian Council , Medical Research , Central Drugs Standards Control Organisation , West Bengal , Join Mint , ஜய்துச் காடிலா , கிருஷ்ணா எல்லா , மாநாடு ஆன் , பாரத் பயோடெக் சர்வதேச , சீரம் நிறுவனம் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , மைய மருந்துகள் தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன் , சீரம் நிறுவனம் ஆஃப் இந்தியா , பாரத் பயோடெக் சர்வதேச லிமிடெட் , ஆண்டு மாநாடு , பயோடெக் இந்தியன் சபை ,

How India plans to ensure safety and efficacy of covid-19 vaccines

How India plans to ensure safety and efficacy of covid-19 vaccines
The meeting of the subject expert committee of Central Drugs Standards Control Organisation has asked Bharat Biotech International and Serum Institute of India for more data on the safety and efficacy of their shots.Premium
3 min read
Share Via
Read Full Story
NEW DELHI: Safety and efficacy are the primary concerns of the government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country.
The government s cautious approach before approving a vaccine is apparent. The meeting of the subject expert committee of Central Drugs Standards Control Organisation on Wednesday asked Bharat Biotech International and Serum Institute of India for more data on the safety and efficacy of their shots and deferred recommending them for emergency use. ....

United Kingdom , Narendra Modi , Rajesh Bhushan , Lalit Kant , Union Health , Bharat Biotech International , Indian Council Of Medical Research , Regulatory Agency , National Health Services , Serum Institute , Central Drugs Standards Control Organisation On , Serum Institute Of India , Oxford University , Central Drugs Standards Control Organisation , Pfizer United Kingdom , Health Secretary Rajesh Bhushan , New Drugs , Clinical Trials Rules , Minister Narendra Modi , Whole Virion , Inactivated Corona Virus Vaccine , Infectious Disease Epidemiologist , Indian Council , Medical Research , Join Mint , ஒன்றுபட்டது கிஂக்டம் ,

US FDA nod may give Pfizer's approval case in India a boost - health

So far, the Indian regulator has not granted regulatory approvals to any vaccine candidate based on data generated during trials held in other countries. | Health ....

United Kingdom , Biontech Covid , Poonam Khetrapal Singh , Dr Reddy Laboratories , World Health Organization , Drug Administration , Bharat Biotech International Ltd , E Ltd , Serum Institute Of India Pvt , Pfizer Inc , Cadila Healthcare Ltd , Central Drugs Standards Control Organisation , Biologicale Ltd , Serum Institute , Laboratories Limited , Wockhardt Limited , Bharat Biotech , East Asia Region , ஒன்றுபட்டது கிஂக்டம் , பூனம் கேட்டிறப்பால் சிங் , டாக்டர் சிவப்பு ஆய்வகங்கள் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , பாரத் பயோடெக் சர்வதேச லிமிடெட் , ஏ லிமிடெட் , சீரம் நிறுவனம் ஆஃப் இந்தியா பிரைவேட் , ஃபைசர் இன்க் ,

8 Covid-19 vaccine candidates scheduled to be manufactured in India: Vardhan

The health minister was digitally addressing the Inter-Ministerial meeting on Vaccination of South Asia against covid-19 by the World Bank on Thursday.Pune-based SII is in a process to manufacture Covishield which undergoing phase 3 stage of the clinical trials ....

United States , United Kingdom , New Delhi , Harsh Vardhan , Indian Council Of Medical Research , Thomas Jefferson University , Bharat Biotech International Ltd , Central Drugs Standards Control Organisation On , India Institute Of Medical Sciences , Serum Institute Of India , Oxford University , World Bank On , South Asia , World Bank , Central Drugs Standards Control Organisation , Serum Institute , Bharat Biotech , Indian Council , Medical Research , India Made Covaxin , All India Institute , Medical Sciences , West Bengal , Active Caseload , New Cases , Recovery Rate ,